Public Calendar: March 2 - 8, 2025

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Sara Brenner, M.D., M.P.H., Acting Commissioner for Food and Drugs

Event Date: 03/03/2025
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: DAYLE CRISTINZIO; 
Non FDA Participant/Group: Deb Autor, Nancy Myers (FDA Alumni Association);

Official Name: Kyle Diamantas, J.D., Acting Deputy Commissioner for Human Foods

No Significant Event

Official Name: Ritu Nalubola, Ph.D., Acting Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Angelique Hebert, Acting Deputy Commissioner for Operations

No Significant Event

Official Name: Michael Rogers, Associate Commissioner for Inspections and Investigations

No Significant Event

Official Name: Jacqueline Corrigan Curay, J.D., M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 03/06/2025
Location: Washington, DC
Subject: American Society of Gene and Cell Therapy, Establishing and Maintaining Access to Gene and Cell Therapy for Rare and Ultrarare Diseases Workshop; Accelerating Rare Disease Gene Therapy Development
FDA Participant/Group: NICOLE VERDUN; JULIA TIERNEY; 
Non FDA Participant/Group: Industry, research, academia, healthcare, and patient advocate stakeholders

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Robert F. Foster, J.D., Chief Counsel

No Significant Event